Pharm Exec Podcast
Recent Licensing Agreement Poised to Advance Company ADC
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:22:51
- More information
Informações:
Synopsis
Jingsong Wang, Chairman of Nona Biosciences, discusses Nona Biosciences’ recent exclusive license agreement with Pfizer Inc. for the development and commercialization of HBM9033, an innovative antibody-drug conjugate (ADC) targeting MSLN, a key antigen in various solid tumors. Wang believes that the partnership will significantly advance Nona's Harbour Mice® platform and ADC ecosystem.
